SFTPD and lung disorder: SP-A and SP-D are surfactant proteins produced in the lungs; however, the serum levels of these proteins have also been shown to correlate with the severity and/or progression of various pulmonary diseases, such as COVID-19 [198–200], interstitial lung disease [201–204], and COPD [205, 206].